ES2177622T3 - Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma. - Google Patents

Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.

Info

Publication number
ES2177622T3
ES2177622T3 ES95904434T ES95904434T ES2177622T3 ES 2177622 T3 ES2177622 T3 ES 2177622T3 ES 95904434 T ES95904434 T ES 95904434T ES 95904434 T ES95904434 T ES 95904434T ES 2177622 T3 ES2177622 T3 ES 2177622T3
Authority
ES
Spain
Prior art keywords
colestipol
pct
manufacturing process
same
active acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95904434T
Other languages
English (en)
Inventor
Walter Muller
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2177622T3 publication Critical patent/ES2177622T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Abstract

UN MEDICAMENTO ORAL CON UN PORTADOR PARA UN PRINCIPIO ACTIVO ACIDO, EL CUAL DISPONE DE AL MENOS UN GRUPO CARBOXILO LIBRE, QUE ESTA UNIDO IONICAMENTE A UN POLIMERO CON GRUPOS DE AMINAS TERCIARIAS, CARACTERIZADO PORQUE EL POLIMERO ES COLESTIPOL O HIDROCLORURO DE COLESTIPOL.
ES95904434T 1994-01-27 1994-12-08 Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma. Expired - Lifetime ES2177622T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2177622T3 true ES2177622T3 (es) 2002-12-16

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95904434T Expired - Lifetime ES2177622T3 (es) 1994-01-27 1994-12-08 Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.

Country Status (22)

Country Link
US (1) US5858344A (es)
EP (1) EP0741574B1 (es)
JP (1) JP3701971B2 (es)
KR (1) KR100439311B1 (es)
AT (1) ATE218371T1 (es)
AU (1) AU697353B2 (es)
CA (1) CA2182417C (es)
CZ (1) CZ291006B6 (es)
DE (2) DE4402379C2 (es)
DK (1) DK0741574T3 (es)
ES (1) ES2177622T3 (es)
FI (1) FI116880B (es)
HU (1) HU223317B1 (es)
IL (1) IL112435A (es)
MY (1) MY113340A (es)
NO (1) NO963143L (es)
NZ (1) NZ277777A (es)
PL (1) PL315619A1 (es)
PT (1) PT741574E (es)
SK (1) SK97296A3 (es)
WO (1) WO1995020394A1 (es)
ZA (1) ZA95638B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
CA2938564C (en) 2006-11-07 2017-04-11 The Procter & Gamble Company Fiber containing compositions and methods of making and using same
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2022259848A1 (ja) 2021-06-07 2022-12-15 国立大学法人筑波大学 高分子化バルプロ酸及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
DE4402379A1 (de) 1995-08-03
JP3701971B2 (ja) 2005-10-05
AU1312795A (en) 1995-08-15
DE59410133D1 (de) 2002-07-11
FI962985A (fi) 1996-07-26
CA2182417A1 (en) 1995-08-03
HU9602041D0 (en) 1996-09-30
HU223317B1 (hu) 2004-05-28
PT741574E (pt) 2002-11-29
DK0741574T3 (da) 2002-09-23
FI962985A0 (fi) 1996-07-26
CZ291006B6 (cs) 2002-11-13
ZA95638B (en) 1995-10-25
PL315619A1 (en) 1996-11-25
CZ221396A3 (en) 1997-01-15
IL112435A (en) 1999-01-26
WO1995020394A1 (de) 1995-08-03
AU697353B2 (en) 1998-10-01
KR970700505A (ko) 1997-02-12
JPH09511488A (ja) 1997-11-18
ATE218371T1 (de) 2002-06-15
EP0741574A1 (de) 1996-11-13
IL112435A0 (en) 1995-03-30
NZ277777A (en) 1997-01-29
US5858344A (en) 1999-01-12
DE4402379C2 (de) 1997-09-25
MY113340A (en) 2002-01-31
FI116880B (fi) 2006-03-31
NO963143D0 (no) 1996-07-26
SK97296A3 (en) 1997-04-09
KR100439311B1 (ko) 2005-08-17
CA2182417C (en) 2007-04-17
NO963143L (no) 1996-09-24
HUT74434A (en) 1996-12-30
EP0741574B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
FI962589A0 (fi) 2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
AU5956398A (en) Remedies for lymphocytic tumors
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
BG101822A (en) Oral dosage forms containing beta-lactam antibiotic
DK312688A (da) Glykkopeptid-antibiotika
ES2177622T3 (es) Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.
DE69935526D1 (de) Supramolekulare komplexe enthaltende arzneimittel
DE59606907D1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
CA2235951A1 (en) Novel uses of mammalian ctla-8 and related reagents
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
ES2134941T3 (es) Pastillas de lactulosa.
BR9808305A (pt) Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor.
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
TR199701334T1 (xx) Antibakteriyel antibiyotikler.
BR9609937A (pt) Composição contendo ácido mefenâmico em associação com codeìna
RU93000551A (ru) Лекарственное средство мазь лингезин